Adeno-associated virus type 2-mediated gene transfer: Role of cellular FKBP52 protein in transgene expression

Journal of Virology

Volumn 75, Issue 19, 2001, Pages 8968-8976

  Qing, K ^a   Hansen, J ^a   Weigel Kelley, K A ^a   Tan, M ^a   Zhou, S ^a   Srivastava, A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL PROTEIN; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 52; IMMUNOSUPPRESSIVE AGENT; PHOSPHOPROTEIN; PROTEIN FKBP52; SERINE; TACROLIMUS; THREONINE; TYROSINE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DNA REPLICATION; DNA SYNTHESIS; DRUG PROTEIN BINDING; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; TRANSGENE;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; DEPENDOVIRUS; GENE THERAPY; GENETIC VECTORS; HELA CELLS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; TACROLIMUS BINDING PROTEINS; TRANSFECTION;

EID: 0034849529     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.19.8968-8976.2001     Document Type: Article

References (57)

1. Biology of adeno-associated virus
2. Development of adeno-associated virus vectors for gene therapy of cystic fibrosis
3. Strategies for efficient gene transfer into hematopoietic cells: The use of adeno-associated virus vectors in gene therapy
4. Epidermal growth factor receptor activation in developing rat kidney
5. Evidence that the FK506-binding protein 56 is required for trafficking of the glucocorticoid receptor from the cytoplasm to the nucleus
6. Intracellular trafficking of adeno-associated virus vectors: Routing to the late endosomal compartment and proteasome degradation
7. Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
8. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors
9. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
10. Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle
11. A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease
12. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector
13. Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts
14. Adeno-associated virus type 2-mediated gene transfer: Altered endocytic processing enhances transduction efficiency in murine fibroblasts
15. Two YY-1-binding proximal elements regulate the promoter strength of the TATA-less mouse ribonucleotide reductase gene
16. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
17. Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector
18. Evidence for gene transfer and expression of factor IX in hemophilia B patients treated with an AAV vector
19. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
20. Expression of the human endogenous retrovirus HTDV/HERV-K is enhanced by cellular transcription factor YY1
21. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors
22. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19ql3-qter
23. Site-specific integration by adeno-associated virus
24. COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus
25. Gene transfer with adeno-associated virus 2 vectors: The growth factor receptor connection
26. Adeno-associated virus 2-mediated gene transfer: Role of epidermal growth factor receptor protein tyrosine kinase in transgene expression
27. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector
28. Casein kinase II phosphorylates Iκ Bα at S-283, S-289, and T-291 and is required for its degradation
29. Phosphorylation of the immunosuppressant FK506-binding protein FKBP52 by casein kinase II: Regulation of HSP90-binding activity of FKBP52
30. Binding of herpes simplex virus immediate-early gene product ICP4 to its own transcription start site
31. Use of adeno-associated virus as a general transduction vector for mammalian cells
32. - subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV
33. Altered beta-adrenergic receptor signaling in heart failure, in vivo gene transfer via adeno and adeno-associated virus
34. - hematopoietic progenitor cells: Donor variation and correlation of transgene expression with cellular differentiation
35. Adeno-associated virus 2-mediated gene transfer in vivo: Organ-tropism and expression of transduced sequences in mice
36. Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo
37. The hsp90-based chaperone system: Involvement in signal transduction from a variety of hormone and growth factor receptors
38. Steroid receptor interactions with heat shock protein and immunophilin chaperones
39. cdc37
40. Adeno-associated virus type 2-mediated gene transfer: Correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo
41. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
42. Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression
43. Casein kinase II phosphorylates p34cdc2 kinase in G1 phase of the HeLa cell division cycle
44. Targeted integration of adeno-associated virus (AAV) into human chromosome 19
45. Chemistry and biology of the immunophilins and their immuno-suppressive ligands
46. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
47. Adeno-associated virus 2-mediated transduction and erythroid lineage-specific expression in human hematopoietic progenitor cells
48. αVβ5 integrin: A co-receptor for adeno-associated virus 2 infection
49. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
50. Gene therapy for human hemoglobinopathies
51. Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: Selective encapsidation of viral genomes in progeny virions
52. Adeno-associated virus type 2 DNA replication in vivo: Mutation analyses of the D sequence in viral inverted terminal repeats
53. Immunoaffinity purification of the epidermal growth factor receptor. Stoichiometry of binding and kinetics of self-phosphorylation
54. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
55. Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice
56. Adeno-associated virus 2-mediated transduction and erythroid cell-specific expression of a human β-globin gene